Physician profile
John M Henry
NPI 1487654877
$1,413.63
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $520 · 2021: $132 · 2022: $141.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $346.51 | 2019-2021 | |
| Astellas Pharma US INC | $338.05 | 2019-2021 | |
| Intuitive Surgical, INC. | $298.19 | 2019-2020 | |
| Abbvie INC. | $134.95 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $122.01 | 2022 | |
| Neotract INC. | $89.40 | 2020 | |
| Teleflex LLC | $32.24 | 2021 | |
| Myovant Sciences INC. | $18.76 | 2022 | |
| Pfizer INC. | $12.86 | 2021 | |
| Rochester Medical Corporation | $12.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.